Allurion Technologies, Inc. (ALUR) - Total Assets
Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) holds total assets worth $13.99 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Allurion Technologies, Inc. - Total Assets Trend (2020–2025)
This chart illustrates how Allurion Technologies, Inc.'s total assets have evolved over time, based on quarterly financial data. Also see Allurion Technologies, Inc. (ALUR) total market value for the company's overall valuation and market capitalisation.
Allurion Technologies, Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Allurion Technologies, Inc.'s total assets of $13.99 Million consist of 81.1% current assets and 18.9% non-current assets. Review Allurion Technologies, Inc. (ALUR) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 34.3% |
| Accounts Receivable | $3.95 Million | 25.1% |
| Inventory | $2.67 Million | 16.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Allurion Technologies, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Allurion Technologies, Inc. stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allurion Technologies, Inc.'s current assets represent 81.1% of total assets in 2025, an increase from 14.3% in 2020.
- Cash Position: Cash and equivalents constituted 34.3% of total assets in 2025, up from 14.3% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.
Allurion Technologies, Inc. Competitors by Total Assets
Key competitors of Allurion Technologies, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.81 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Eurobio Scientific SA
PA:ALERS
|
France | €259.11 Million |
|
Profound Medical Corp
TO:PRN
|
Canada | CA$62.28 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
Allurion Technologies, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.30 | 2.09 | 2.78 |
| Quick Ratio | 0.25 | 1.88 | 2.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-25.95 Million | $17.27 Million | $1.41 Million |
Allurion Technologies, Inc. - Advanced Valuation Insights
This section examines the relationship between Allurion Technologies, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -51.9% |
| Total Assets | $15.77 Million |
| Market Capitalization | $1.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Allurion Technologies, Inc.'s assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Allurion Technologies, Inc.'s assets decreased by 51.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Allurion Technologies, Inc. (2020–2025)
The table below shows the annual total assets of Allurion Technologies, Inc. from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $15.77 Million | -51.93% |
| 2024-12-31 | $32.81 Million | -54.24% |
| 2023-12-31 | $71.71 Million | +39.60% |
| 2022-12-31 | $51.37 Million | +30.54% |
| 2021-12-31 | $39.35 Million | +11825.81% |
| 2020-12-31 | $329.96K | -- |
About Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring to… Read more